IDEXX Laboratories financials at a glance

Year Year 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2021 2022 2023 2024
Rev. Revenue
$2.71B $2.41B $2.21B $1.97B $1.78B $1.60B $1.49B $1.38B $1.29B $1.22B $1.10B $1.03B $1.02B $922.56M $739.12M $638.10M $549.18M $3.22B $3.37B $3.66B $0.00M
GM % Gross Margin %
58.04% 56.73% 56.10% 55.73% 54.94% 55.58% 54.93% 54.91% 54.06% 53.05% 52.44% 51.01% 51.73% 50.35% 51.35% 50.64% 50.81% 58.76% 59.52% 59.82% 0.00%
OM Operating Margin
25.66% 23.53% 22.20% 20.98% 19.85% 19.24% 18.16% 19.37% 20.30% 19.38% 18.48% 17.20% 16.99% 14.87% 17.31% 18.23% 19.67% 28.99% 26.69% 29.97% 0.00%
EPS Earnings Per Share
$0.59 $0.67 $0.79 $0.95 $1.01 $1.19 $1.39 $1.57 $1.79 $2.00 $2.11 $2.44 $3.28 $4.26 $4.89 $6.70 $8.60 $8.03 $10.06 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0 0.00% 0.00% 0.00% 0.00% 0 0 0 0 0.00% 0.00% 0 0.00% 0.00% 0.00% 0
Sha. Shares
85.3m 85.78m 86.23m 87.22m 89.66m 90.96m 95.36m 103.79m 109.35m 112.3m 115.01m 117.18m 119.12m 122.46m 125.2m 128.22m 137.02m 84.79m 82.82m 83.05m 83.05m
OCF Operating Cash Flow
$648.06M $459.16M $400.08M $373.28M $338.94M $221.80M $235.85M $246.00M $222.41M $217.91M $178.83M $174.95M $143.31M $135.12M $109.83M $116.55M $95.38M $755.55M $542.98M $906.51M $0.00M
FCF Free Cash Flow
$541.11M $304.19M $284.33M $298.89M $269.78M $133.44M $175.32M $168.38M $164.79M $168.24M $139.93M $124.29M $53.34M $68.88M $63.69M $89.74M $63.67M $636.00M $394.15M $847.40M $0.00M
FCFS Free Cash Flow Per Share
$6.33 $3.53 $3.19 $3.38 $3.06 $1.50 $1.75 $1.57 $1.49 $1.47 $1.21 $1.05 $0.41 $0.56 $0.51 $0.69 $0.47 $7.46 $4.59 $9.30 $0.00